Clinical Trial Update: Safety Study of a Single Dose of Pneumococcal Whole-Cell Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating a single-dose pneumococcal whole-cell vaccine in healthy adults has completed, assessing safety and tolerability with relevanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Otitis Media

Drugs mentioned

• Pneumococcal whole-cell vaccine (pneumococcal whole-cell vaccine)

Snippet

Sponsor: Serum Life Science Europe GmbH | Conditions: PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE, Prevention of Pneumococcal-induced Acute Otitis Media | Phase 1 | Status: COMPLETED